Ethics of Studies of Drugs in Pregnancy
Tóm tắt
Pregnant women with illness require efficacious and safe drug therapy during pregnancy; however, their treatment is often hindered by a lack of information regarding the use of medications during pregnancy. Ethical challenges are encountered in conducting drug trials in pregnant women, who are often excluded from participation due to fear of harm to the fetus. However, as the health of the fetus is ultimately affected by that of the pregnant woman, inclusion of pregnant women in studies of medications that they may require for their own benefit may also benefit the unborn child. The principle of autonomy argues for the pregnant woman being able to make an informed choice to take part in a clinical trial, and the principle of justice dictates that she not be denied the benefits of drug research.
Tài liệu tham khảo
Baylis F. Pregnant women deserve better. Nature. 2010;465:689–90.
Lyerly AD, Little MO, Faden R. The second wave: toward responsible inclusion of pregnant women in research. Int J Fem Approaches Bioeth. 2008;1:5–22.
Schonfeld T, Schmid KK, Brown JS, Amoura NJ, Gordon B. A pregnancy testing policy for women enrolled in clinical trials. IRB. 2013;35:9–15.
Casey MJ, O’Brien R, Rendell M, Salzman T. Ethical dilemma of mandated contraception in pharmaceutical research at Catholic medical institutions. Am J Bioeth. 2012;12:34–7.
Shields KE, Lyerly AD. Exclusion of pregnant women from industry-sponsored clinical trials. Obstet Gynecol. 2013;122:1077–81.
Dominguez V, Ramos N, Torrents A, Garcia D, Carné X. Clinical trials during pregnancy: what has been done. Eur J Clin Pharmacol. 2012;68:455–8.
Blehar MC, Spong C, Grady C, Goldkind SF, Sahin L, Clayton JA. Enrolling pregnant women: issues in clinical research. Womens Health Issues. 2013;23:e39–45.
Allesee L, Gallagher CM. Pregnancy and protection: the ethics of limiting a pregnant woman’s participation in clinical trials. J Clin Res Bioeth. 2011;. doi:10.4172/2155-9627.1000108.
Department of Health and Human Services. Code of Federal Regulations Title 45 Part 46 Protection of Human Subjects. 2009. http://www.hhs.gov/ohrp/policy/ohrpregulations.pdf. Accessed 10 April 2014.
Chervenak FA, McCullough LB. An ethically justified framework for clinical investigation to benefit pregnant and fetal patients. Am J Bioeth. 2011;11:39–49.
Canadian Institutes of Health Research. Natural Sciences and Engineering Research Council of Canada, and Social Sciences and Humanities Research Council of Canada. Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans; 2010.
Health Canada. Guidance Document: Considerations for Inclusion of Women in Clinical Trials and Analysis of Sex Differences. 2013. http://www.hc-sc.gc.ca/dhp-mps/prodpharma/applic-demande/guide-ld/clini/womct_femec-eng.php. Accessed 10 April 2014.
Regulation (EU) No. 536/2014 of the European Parliament and of the Council Of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC. Off J Eur Union 2014;57:1–76.
DiGiovanni LM. Ethical issues in obstetrics. Obstet Gynecol Clin N Am. 2010;37:345–57.
Lyerly AD, Little MO, Faden RR. Reframing the framework: toward fair inclusion of pregnant women as participants in research. Am J Bioeth. 2011;11:50–2.
Strong C. Moral status and the fetus: continuation of a dialogue. Am J Bioeth. 2011;11:52–4.
Shalowitz DI, Ecker JL. Research in pregnancy: back to first principles. Am J Bioeth. 2011;11:56–7.
Minkoff H, Marshall MF, Liaschenko J. The fetus, the “potential child”, and the ethical obligations of obstetricians. Obstet Gynecol. 2014;123:1100–3.
Shivakumar G, Inrig S, Sadler JZ. Community, constituency, and morbidity: applying Chervenak and McCullough’s criteria. Am J Bioeth. 2011;11:57–60.
Townsend SF. Ethics for the pediatrician: obstetric conflict: when fetal and maternal interests are at odds. Pediatr Rev. 2012;33:33–7.
Daw JR, Hanley GE, Greyson DL, Morgan SG. Prescription drug use during pregnancy in developed countries: a systematic review. Pharmacoepidemiol Drug Saf. 2011;20:895–902.
Adam MP, Polifka JE, Friedman JM. Evolving knowledge of the teratogenicity of medications in human pregnancy. Am J Med Genet C Semin Med Genet. 2011;157:175–82.
Baylis F, Kaposy C. Wanted: inclusive guidelines for research involving pregnant women. J Obstet Gynaecol Can. 2010;32:473–6.
Lyerly AD, Faden RR. Mothers matter: ethics and research during pregnancy. Virtual Mentor. 2013;15:775–8.
van Trigt AM, Waardenburg CM, Haaijer-Ruskamp FM, de Jong-van de Berg LT. Questions about drugs: how do pregnant women solve them? Pharm World Sci. 1994;16:254–9.
Olesen C, Søndergaard C, Thrane N, Nielsen GL, de Jong-van den Berg L, Olsen J. L. Epidemiology. 2001;12:497–501.
Nielsen MJ, Nørgaard M, Holland-Fisher P, Christensen LA. Self-reported antenatal adherence to medical treatment among pregnant women with Crohn’s disease. Aliment Pharmacol Ther. 2010;32:49–58.
Julsgaard M, Nørgaard M, Hvas CL, Buck D, Christensen LA. Self-reported adherence to medical treatment prior to and during pregnancy among women with ulcerative colitis. Inflamm Bowel Dis. 2011;17:1573–80.
Macklin R. Enrolling pregnant women in biomedical research. Lancet. 2010;375:632–3.
Lyerly AD, Namey EE, Gray B, Swamy G, Faden RR. Women’s views about participating in research while pregnant. IRB. 2012;34:1–8.
Rodger MA, Makropoulos D, Walker M, Keely E, Karovitch A, Wells PS. Participation of pregnant women in clinical trials: will they participate and why? Am J Perinatol. 2003;20:69–76.
Mohanna K, Tunna K. Withholding consent to participate in clinical trials: decisions of pregnant women. Br J Obstet Gynaecol. 1999;106:892–7.
Haas DM, Wunder K, Wolf JG, Denne SC. Women’s health care providers’ attitudes toward research in pregnancy. J Reprod Med. 2010;55:108–14.
Schonfeld T. The perils of protection: vulnerability and women in clinical research. Theor Med Bioeth. 2013;34:189–206.
Liaschenko J, DeBruin D, Marshall MF. The two-patient framework for research during pregnancy: a critique and a better way forward. Am J Bioeth. 2011;11:66–8.
Baylis F, Halperin SA. Research involving pregnant women: trials and tribulations. Clin Invest. 2012;2:139–46.
Koren G. Ethical framework for observational studies of medicinal drug exposure in pregnancy. Teratology. 2002;65:191–5.
Strong C. How should risks and benefits be balanced in research involving pregnant women and fetuses? IRB. 2011;33:1–5.
American College of Obstetricians and Gynecologists. Committee on Ethics; American Academy of Pediatrics, Committee on Bioethics. Maternal-fetal intervention and fetal care centers. Pediatrics. 2011;128:e473–8.
Gedeon C, Nava-Ocampo AA, Koren G. Ethical issues in pharmacologic research in women undergoing pregnancy termination: a systemic review and survey of researchers. Obstet Gynecol Int. 2012;. doi:10.1155/2012/724591.
Ward RM, Sherwin CM. Ethics of drug studies in the newborn. Pediatr Drugs. 2015;17(1)
Noel-Weiss J, Woodend AK, Kujawa-Myles S. Lactation and breastfeeding research studies: who should provide consent for the neonate? J Hum Lact. 2010;26:180–2.
Kaposy C, Baylis F. The common rule, pregnant women, and research: no need to “rescue” that which should be revised. Am J Bioeth. 2011;11:60–2.